Suppr超能文献

不仅仅是对Toll样受体的补充:补体与Toll样受体在固有免疫和炎症中的协同作用及相互作用

More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.

作者信息

Hajishengallis George, Lambris John D

机构信息

Department of Microbiology, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA.

Perelman School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Immunol Rev. 2016 Nov;274(1):233-244. doi: 10.1111/imr.12467.

Abstract

Complement and Toll-like receptors (TLRs) play key roles in the host immune response and are swiftly activated by infection or other types of immunological stress. This review focuses on the capacity of complement and TLRs to engage in signaling crosstalk, ostensibly to coordinate immune and inflammatory responses through synergistic or antagonistic (regulatory) interactions. However, overactivation or dysregulation of either system may lead-often synergistically-to exaggerated inflammation and host tissue injury. Intriguingly, moreover, certain pathogens can manipulate complement-TLR crosstalk pathways in ways that undermine host immunity and favor their persistence. In the setting of polymicrobial inflammatory disease, subversion of complement-TLR crosstalk by keystone pathogens can promote dysbiosis. Knowledge of the molecular mechanisms underlying complement-TLR crosstalk pathways can, therefore, be used productively for tailored therapeutic approaches, such as, to enhance host immunity, mitigate destructive inflammation, or counteract microbial subversion of the host response.

摘要

补体和Toll样受体(TLRs)在宿主免疫反应中发挥关键作用,并在感染或其他类型的免疫应激下迅速被激活。本综述重点关注补体和TLRs参与信号串扰的能力,表面上是通过协同或拮抗(调节)相互作用来协调免疫和炎症反应。然而,这两个系统的过度激活或失调通常会协同导致炎症反应过度和宿主组织损伤。此外,有趣的是,某些病原体可以通过破坏宿主免疫力并有利于其持续存在的方式来操纵补体-TLR串扰途径。在多微生物炎症性疾病的情况下,关键病原体对补体-TLR串扰的破坏可促进生态失调。因此,了解补体-TLR串扰途径的分子机制可有效地用于定制治疗方法,例如增强宿主免疫力、减轻破坏性炎症或对抗宿主反应的微生物破坏。

相似文献

2
Crosstalk pathways between Toll-like receptors and the complement system.
Trends Immunol. 2010 Apr;31(4):154-63. doi: 10.1016/j.it.2010.01.002. Epub 2010 Feb 10.
3
Crosstalk between complement and toll-like receptors.
Toxicol Pathol. 2012;40(2):174-82. doi: 10.1177/0192623311428478. Epub 2011 Nov 22.
4
Microbial hijacking of complement-toll-like receptor crosstalk.
Sci Signal. 2010 Feb 16;3(109):ra11. doi: 10.1126/scisignal.2000697.
5
The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
Atherosclerosis. 2015 Aug;241(2):480-94. doi: 10.1016/j.atherosclerosis.2015.05.038. Epub 2015 Jun 5.
6
Crosstalk between toll-like receptors and hypoxia-dependent pathways in health and disease.
J Investig Med. 2016 Feb;64(2):369-75. doi: 10.1097/JIM.0000000000000228. Epub 2016 Jan 11.
7
Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
Mol Cell Endocrinol. 2007 Sep 15;275(1-2):30-42. doi: 10.1016/j.mce.2007.04.014. Epub 2007 May 13.
8
Complement and dysbiosis in periodontal disease.
Immunobiology. 2012 Nov;217(11):1111-6. doi: 10.1016/j.imbio.2012.07.007.
10
Regulation of B cell functions by Toll-like receptors and complement.
Immunol Lett. 2016 Oct;178:37-44. doi: 10.1016/j.imlet.2016.07.015. Epub 2016 Jul 30.

引用本文的文献

1
The trapping of live neutrophils by macrophages during infection.
Cell Death Dis. 2025 Jul 3;16(1):488. doi: 10.1038/s41419-025-07808-5.
6
Neutrophil diversity and function in health and disease.
Signal Transduct Target Ther. 2024 Dec 6;9(1):343. doi: 10.1038/s41392-024-02049-y.
8
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults.
Allergy. 2024 Sep;79(9):2502-2523. doi: 10.1111/all.16231. Epub 2024 Jul 20.
9
Toll-like receptors and integrins crosstalk.
Front Immunol. 2024 Jun 10;15:1403764. doi: 10.3389/fimmu.2024.1403764. eCollection 2024.

本文引用的文献

3
Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis.
Crit Care. 2015 Nov 27;19:415. doi: 10.1186/s13054-015-1129-9.
5
Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.
Mol Oral Microbiol. 2016 Feb;31(1):3-17. doi: 10.1111/omi.12129. Epub 2015 Oct 7.
6
7
The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
Atherosclerosis. 2015 Aug;241(2):480-94. doi: 10.1016/j.atherosclerosis.2015.05.038. Epub 2015 Jun 5.
8
Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Thromb Haemost. 2015 Oct;114(4):848-58. doi: 10.1160/TH14-12-1075. Epub 2015 Jun 18.
9
Complement System Part II: Role in Immunity.
Front Immunol. 2015 May 26;6:257. doi: 10.3389/fimmu.2015.00257. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验